Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of XOMA 052 in Type 2 Diabetes
NCT00513214Phase 2Completed
- Sponsor
- XOMA
- Start
- Jul 2007
- Primary completion
- Jun 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of gevokizumab in type 2 diabetes mellitus (T2DM), sponsored by XOMA. Started Jul 2007; status: completed.
02
Drugs
gevokizumab
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00513214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00513214.